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A poliovirus-specific polyuridylic acid [poly(U)] polymerase that copies a 
polyadenylic acid template complexed to an oligouridylic acid primer was isolated 
from the membrane fraction of infected HeLa cells and was found to sediment at 
4 to 58 on a linear 5 to 20% glycerol gradient. When the poly(U) polymerase was 
isolated from cells labeled with [358]methionine and was analyzed by glycerol 
gradient centrifugation and polyacrylamide gel electrophoresis, the position of 
only one viral protein was found to correlate with the location of enzyme activity. 
This protein had an apparent molecular weight of 62,500 based on its electropho-
retic mobility relative to that of several molecular weight standards and was 
designated p63. When the poly(U) polymerase was isolated from the soluble 
fraction of a cytoplasmic extract, the activity was found to sediment at about 78. 
In this case, however, both p63 and NCVP2 (77,000-dalton precursor of p63) 
cosedimented with the 78 activity peak. When the 78 polymerase activity was 
purified by phosphocellulose chromatography, both p63 and NCVP2 were found 
to co-chromatograph with poly(U) polymerase activity. The poliovirus replicase 
complexed with its endogenous RNA template was isolated from infected cells 
labeled with [358]methionine and was centrifuged through a linear 15 to 30% 
glycerol gradient. The major viral polypeptide component in a 268 peak of 
replicase activity was p63, but small amounts of other poliovirus proteins were 
also present. When the replicase-template complex was treated With RNase T1 
before centrifugation, a single peak of activity was found that sedimented at 208 
and contained only labeled p63. Thus, p63 was found to be the only viral 
polypeptide in the replicase bound to its endogenous RNA template, and appears 
to be active as a poly(U) polymerase either as a monomer protein or as a 78 
complex. 
The poliovirus single-stranded RNA genome 
is replicated by an RNA-dependent RNA po-
lymerase (replicase) found in the cytoplasm of 
infected cells (4). Poliovirion and mRNA 
syntheses take place in a replication complex 
that consists of the replicase and a replicative 
intermediate composed of one complete strand 
of complementary (negative-strand) RNA and 
several nascent chains of plus-strand RNA (5, 
18). The replicase probably contains one or more 
virus-coded proteins, but evidence about which 
viral polypeptide is responsible for replicase ac-
tivity has been circumstantial. Replicase activity 
has not been found in extracts of uninfected 
cells, and poliovirus temperature-sensitive mu-
tants for RNA synthesis have been reported 
(13). Partial purification of the replication com-
plex indicated that a noncapsid viral protein 
t Present address: Department of Immunology and Medi-
cal Microbiology, College of Medicine, University of Florida, 
Gainesville, FL 32610. 
believed to be NCVP4 was the predominant 
viral protein component of the complex, but 
small amounts of other viral and host proteins 
were also present (9, 23). An RNA-dependent 
RNA polymerase has been isolated from cells 
infected with encephalomyocarditis virus but, 
when the most purified form of the polymerase 
was analyzed by polyacrylamide gel electropho-
resis, at least four virus-coded polypeptides were 
present, and thus identification of the replicase 
protein(s) was not possible (24). 
We have previously reported the isolation of 
a soluble poliovirus-specific RNA-dependent 
RNA polymerase that will copy a polyadenylic 
acid [poly(A)] template complexed to an oli-
gouridylic acid [oligo(U)] primer (15). The po-
lymerase requires both poly(A) and oligo(U) for 
activity, is not found until about 2 h postinfec-
tion, increases in activity until about 5 h post-
infection, and is recovered from the membrane 
fraction of cells. Because poliovirus infection 
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leads to a rapid inhibition of host protein syn-
thesis (22), the above finding suggests that the 
polyuridylic acid [poly(U)] polymerase is com-
posed of one or more virus-coded proteins. When 
the poly(U) polymerase was analyzed by glyc-
erol gradient centrifugation, it was found to sed-
iment at 4 to 58 (15). We report here the iden-
tification of a virus-specific protein of apparent 
molecular weight 62,500 (p63) that is associated 
with this poly(U) polymerase activity. A soluble 
form of the virus-specific poly(U) polymerase 
has also been identified that sediments at about 
78 and that contains both p63 and the precursor 
of p63, NCVP2. A protein of the same molecular 
weight as p63 was the only virus-coded protein 
in a highly purified form of the endogenous RNA 
replication complex. This polypeptide therefore 
appears to be the major viral protein constituent 
of the poliovirus replicase. 
MATERIALS AND METHODS 
Extracts of poliovirus-infected cells. Suspen-
sion cultures of HeLa cells were infected with polio-
virus type 1 as described previously (26) and were 
treated with 5 p.g of actinomycin D per ml at 15 min 
postinfection. The infected cells (100 ml at 4 X 106 /ml) 
were collected by centrifugation at 3.5 to 5 h postin-
fection, washed once in Earle saline, suspended in 10 
ml of 10 mM Tria-hydrochloride (pH 7.5)-10 mM 
NaCl-1.5 mM MgCh, and broken by three cycles of 
freezing and thawing. When the poly(U) polymerase 
was isolated, the cells were normally broken with a 
Dounce homogenizer. 
Fractionation of cell extracts. The poly(A)-de-
pendent poly(U) polymerase was isolated as previ-
ously described (15) and as outlined in Fig. 1. The 
endogenous replication complex was isolated by meth-
ods similar to those described by Lundquist et al. (23) 
and as outlined in Fig. 1. A 10-ml volume of cell extract 
was centrifuged at 2,000 X g for 5 min, and the precip-
itate was suspended in 10 ml of 10 mM Tria-hydro-
chloride (pH 8.0)-10 mM NaCl (TN buffer) containing 
1% (vol/vol) Nonidet P-40 and 0.5% (wt/vol) sodium 
deoxycholate. The nuclei were removed by centrifu-
gation at 4,000 X g for 5 min, and the resulting super-
natant was centrifuged at 200,000 x g for 1.5 h to 
sediment the replicase-template complex. This sedi-
ment was suspended in 1 ml of TN buffer, 0.25 ml of 
10 M LiCl was added, and the solution was allowed to 
stand overnight at 0°C. When the solution was stored 
at -20°C, significant losses in replicase activity were 
observed. The precipitate formed in the 2 M LiCl 
solution was collected by centrifugation at 12,000 X g 
for 5 min in a Brinkmann microcentrifuge. The pellet 
was washed once in TN buffer containing 2 M LiCl 
and then suspended in TN buffer alone. The resus-
pended LiCl pellet (fraction IV, Fig. 1) was stored at 
0°C with little loss in activity during a period of 2 to 
3weeks. 
Polymerase assays. The poly(A)-dependent 
poly(U) polymerase was assayed for 30 min at 30°C as 
described previously (15). The replicase complexed 
with its endogenous RNA template was assayed as 
follows. In a standard reaction, a 50-,.U. volume of 
enzyme was assayed in 125 ,.U of a solution containing: 
50 mM N-2-hydroxyethyl piperazine-N'-2-ethanesul-
fonic acid (HEPES buffer; pH 8.0); 8 mM magnesium 
acetate; 8 J.tM [5,6-3H]UTP (5,500 cpm/pmol); 1 mM 
each GTP, ATP, and CTP; 4 mM phosphoenolpyruvic 
acid; pyruvate kinase (3 U/ml); 10 p.g of actinomycin 
D per ml; and 10 mM dithiothreitol. The assay was 
for 30 min at 37°C. Enzymatic activity was measured 
by collecting the labeled product on membrane filters 
(Millipore Corp., 0.45 ,an) after precipitation with 7% 
trichloroacetic acid (0.33 saturated with sodium pyro-
phosphate) in the presence of 100 to 200 p.g of added 
carrier RNA. The filters were dissolved in 5 ml of Bray 
scintillation fluid (New England Nuclear Corp.) and 
then counted after the addition of 10 ml of Aquasol-2 
scintillation fluid (New England Nuclear Corp.). Add-
ing the Aquasol-2 increased the efficiency of counting 
about twofold. Whenever asS-labeled proteins were 
present during polymerase assays, the acid-precipita-
ble ass counts, in addition to normal background ra-
dioactivity, were subtracted. 
Polyacrylamide gel electrophoresis. Proteins 
were precipitated with acetone, using 5 p.g of cyto-
chrome c as the carrier protein. Residual acetone was 
removed by evaporation, in vacuo, and the precipitate 
was dissolved in 20 ,.U of electrophoresis sample buffer 
(20) and heated at 95 to 100°C for 3 min. Samples 
were analyzed by electrophoresis on 12.5% polyacryl-
amide slab gels in the presence of sodium dodecyl 
sulfate (NaDodSO.). The procedure was as described 
by Laemmli (20), except that the running gel buffer 
was 1.5 mM Tria-hydrochloride (pH 8.0), the stacking 
gel buffer was 0.5 M Tria-hydrochloride (pH 6.8), and 
the electrode buffer was prepared with 6 g of Tris base, 
28.8 g of glycine, and 1 g of NaDodSO. per liter of 
buffer. The gels were run at 150 V (constant voltage) 
for about 3.5 h, fixed, stained with Coomassie brilliant 
blue, and destained in the presence of a mixed-bed 
resin (AG501-X8 D, Bio-Rad Laboratories). To in-
crease the sensitivity of detection, some gels were 
equilibrated with a 2,5-diphenyloxazole (PPO)-
dimethyl sulfoxide solution by the procedure of Bon-
nar and Laskey (6). The gels were dried and autora-
diographed at -70°C, using Kodak XR-5 film. The 
molecular weight standards used in this study were 
bovine serum albumin (68,500), ovalbumin (45,000), 
vesicular stomatitis virus N protein (52,500), and ve-
sicular stomatitis virus G protein synthesized in vitro 
(63,500) (19). 
Glycerol gradient centrifugation. Because su-
crose precipitated from solutions when acetone was 
added to precipitate proteins, glycerol was used to 
form the gradients used in this study. Samples of 0.5 
to 0.7 ml each were centrifuged through 10.8-ml gra-
dients, using an SW41 rotor (Spinco) at 4°C, as de-
scribed in the figure legends. When gradients were 
collected from the top, a collection device from Hoefer 
Scientific Instruments was used; 50% glycerol was 
pumped through a hypodermic needle into the bottom 
of the centrifuge tube. 
Phosphocellulose chromatography. Phospho-
cellulose was prepared by the method of Burgess (7). 
The resin was equilibrated with 50 mM Tris (pH 8.0), 
and a column (0.8 by 6 em) was prepared. The column 
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was then equilibrated and washed with 50 ml of 50 
mM Tris (pH 8.0)-20% glycerol-0.5% Nonidet P-40-2 
mM dithiothreitol-10 p.g of ovalbumin per ml (TGND-
OA). The polymerase sample in TN buffer-20% glyc-
erol (12 ml) was mixed with 12 ml of TGND-OA buffer 
and applied to the column at a flow rate of 0.2 ml/min. 
The column was washed with 20 ml of TGND-OA 
buffer and then eluted with a 60-mllinear gradient of 
0 to 1 M KCl in TGND-OA. Fractions of 0.9 ml each 
were collected and stored at 4 °C. 
Materials. [5,6-3H]UTP was obtained from New 
England Nuclear Corp. in a 50% ethanol solution. To 
remove the ethanol, the solution was reduced to 0.1 
its original volume with a Buchler Evapomix fraction 
evaporator. 358-labeled poliovirions were purified by 
differential centrifugation and by banding the virus in 
a CsCl density gradient (12). Vesicular stomatitis virus 
proteins labeled with [35S]methionine were synthe-
sized in a cell extract in vitro (19). The sources for 
other materials were as previously described. 
RESULTS 
To compare the viral protein components of 
the poly(U) polymerase and the endogenous rep-
licase, a crude fractionation was first achieved. 
In each fraction, total endogenous activity and 
poly(U) polymerase activity were separately 
measured (Table 1). The membrane-bound com-
ponents of the infected cells were extracted with 
detergents and separated into components sol-
uble or precipitated in 2 M LiCl (Fig. 1). The 
fraction with the majority of the endogenous 
activity (fraction IV, Fig. 1) was recovered by 
detergent extraction of a "nuclear" fraction 
(large membrane vesicles) and by precipitation 
in 2M LiCl (23). The majority of the membrane-
bound poly(U) polymerase was recovered in 
fraction I (Fig. 1) by detergent extraction of a 
small-membrane-vesicle fraction that was solu-
ble after 2M LiCl treatment (15). Although not 
shown in Table 1, a significant amount of 
poly(U) polymerase activity was also recovered 
directly as a soluble protein in a 20,000 x g (or 
200,000 X g) supernatant of the cytoplasmic 
extract (fraction VI, Fig. 1). 
Poly(U) polymerase protein. To analyze 
the polypeptide composition of the poly(U) po-
lymerase, the detergent-solubilized activity 
(fraction I) was sedimented through a glycerol 
gradient. As reported earlier (15), it sedimented 
at 4 to 5S at the approximate position of bovine 
serum albumin (molecular weight, 68,500) (Fig. 
2). If the infected cells were labeled with 
[ 35S]methionine and each glycerol gradient frac-
tion was analyzed by polyacrylamide gel electro-
phoresis, a single viral protein was found to 
correlate with the location of enzyme activity 
(Fig. 2). This polypeptide had a molecular 
weight of about 62,500 compared with those of 
a variety of standards and was one of the labeled 
protein bands that was found in cytoplasmic 
J. VIROL. 
TABLE 1. RNA polymerase activity in fractions 
from poliovirus-infected cells" 
Cell fraction Total endogenous Total poly(U) po-
replicase (pmol of lymerase (pmol of 
assayed NTP incorporated) UTP incorporated) 
I 
II 
III 
IV 
v 
60 
580 
<0.1 
1,304 
<0.1 
2,550 
64 
552 
448 
1,840 
a Poliovirus-infected cells (8 X 108 ) were collected 
at 3.5 h, broken by freezing and thawing, and fraction-
ated as indicated in Fig. 1. Polymerase activity was 
measured, using [ 3H]UTP as the labeled substrate, 
and the values for endogenous replicase activity rep-
resent the calculated picomoles of all four ribonucleo-
side triphosphates incorporated. 
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FIG. 1. Fractionation of poliovirus-infected cells. 
Fractions designated by roman numerals were as-
sayed as described in Table 1. NP40, Nonidet P-40; 
DOC, deoxycholate. 
extracts of poliovirus-infected cells (lanes A and 
B, Fig. 2). Although other viral polypeptides 
were also present in the gradient, most were 
known virion constituents (lane C, Fig. 2), and 
none was distributed selectively in the enzymat-
ically active fractions. It therefore appears that 
the poly(U) polymerase solubilized from cellular 
membranes consists of a single viral polypeptide, 
which we will denote p63. 
When the poly(U) polymerase activity in the 
soluble portion of the cytoplasm (fraction VI, 
Fig. 1) was analyzed by glycerol gradient cen-
trifugation, it was found to sediment signifi-
cantly faster than the membrane-associated po-
lymerase extracted with detergent and 2 M LiCl 
(Fig. 3). The soluble enzyme sedimented at 
about 78 when compared with a bovine serum 
albumin sedimentation marker run in a parallel 
gradient. Analysis of the viral proteins sedi-
menting with the 7S polymerase by polyacryl-
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FIG. 2. Glycerol gradient centrifugation (top) and polyacry amide gel electrophoresis (bottom) of membrane-
associated poly(U) polymerase. Cell fraction I was isolated from cells labeled with [M'Sjmethionine (2.5 to 4 
h) and was centrifuged on a 5 to 20% glycerol gradient at 35,000 rpm for 39.5 hat 4°C. The gradient was 
collected in 0.5-ml fractions from the bottom, and part of each fraction was assayed for poly(U) polymerase 
activity. The proteins in the remaining portion of each fraction were analyzed by NaDodSO.-polyacrylamide 
gel electrophoresis. Fractions 1 through 13 were analyzed on the gel shown at the left, and fractions 14 
through 21 were analyzed on the gel shown at the right. The direction of centrifugation was from right to left. 
l2l>J-labeled bovine serum albumin and cytochrome c (Cyt c) were used as sedimentation markers and were 
analyzed in a parallel gradient. Lanes A and B contained 35S-labeled cytoplasmic poliovirus proteins; and 
lane 3 contained 35S-labeled poliovirion proteins and a bovine serum albumin marker that was located by 
staining the gel. 
amide gel electrophoresis revealed that p63 and 
NCVP2 (the precursor of p63) cosedimented 
with polymerase activity (Fig. 4). This was con-
firmed by cutting out and counting the labeled 
protein bands from each lane in the gel. The 
amounts of radioactivity recovered in p63 and 
NCVP2 were maximal in the same fraction that 
had maximal polymerase activity (fraction 12, 
Fig. 4) (data not shown). Approximately three 
times as much radioactivity was recovered in 
NCVP2 as in p63 in the peak fraction of polym-
erase activity. This ratio increased on the lead-
ing side of the peak (5.0 in fraction 17, Fig. 4) 
and decreased on the trailing side of the peak 
(1.4 in fraction 8, Fig. 4) . The bands for NCVP2 
in lanes 8 to 12 (Fig. 4) were distorted by unla-
beled host proteins migrating at about the same 
position as NCVP2. The distribution of the other 
viral proteins in the gradient was not found to 
correlate with enzyme activity. 
The 78 polymerase activity from the glycerol 
gradient was purified further by gradient elution 
from phosphocellulose. A single peak of polym-
erase activity was found eluting from the column 
at about 0.14 M KCl (Fig. 5). Polyacrylamide gel 
electrophoresis revealed that both p63 and 
NCVP2 co-chromatographed with the poly(U) 
polymerase activity (Fig. 5). About 3.5 times as 
much radioactivity was recovered in NCVP2 as 
in p63. The p63 band in fraction 56 was diffused 
by a large unlabeled protein band running in 
approximately the same position in the gel. The 
two other major viral proteins appeared to elute 
slightly ahead of the polymerase activity peak. 
Therefore, p63 was found to cosediment with 
both the 48 polymerase activity and the 78 
polymerase activity and to co-chromatograph 
with the polymerase activity on phosphocellu-
lose. NCVP2 was also found to cosediment with 
the 78 polymerase and to co-chromatograph 
with the polymerase on phosphocellulose. The 
p63 component alone appears to be active as a 
poly(U) polymerase, but the activity of NCVP2 
alone is uncertain. Although a significant 
amount of NCVP2, was recovered in fraction 1 
(Fig. 2), little poly(U) polymerase activity was 
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Fraction number 
FIG. 3. Centrifugation of the poly(U) polymerase 
activity isolated from the soluble and membrane frac-
tions of the cytoplasm. The soluble enzyme (fraction 
VI, Fig. 1) (0) and the detergent-extracted enzyme 
(fraction I, Fig. 1) (e) were isolated from cells infected 
for 4.5 h. A 0.5-ml portion of each was analyzed in 
parallel by centrifugation through 5 to 20% glycerol 
gradients at 25,000 rpm for 40 h. The gradients were 
collected from the bottom in 0.5-ml fractions, and 
each fraction was assayed for poly(U) polymerase 
activity. An 125I-labeled bovine serum albumin (BSA) 
sedimentation marker was analyzed in a parallel 
gradient. 
detected. Further investigation is required to 
establish whether or not NCVP2 alone has po-
lymerase activity. 
Viral proteins of endogenous replicase. 
To define the protein of the endogenous repli-
case, virus-specific proteins were labeled with 
[ 358]methionine from 1 h, 50 min to 3 h, 30 min 
postinfection, and the fraction enriched in en-
dogenous activity (fraction IV, Table 1) was 
prepared. This fraction (lane B, Fig. 6) contained 
most of the labeled proteins found in cytoplas-
mic extracts (lanes A and C, Fig. 6). When this 
fraction was centrifuged through a 15 to 30% 
glycerol gradient, a peak of endogenous replicase 
activity was found sedimenting at about 268 
along with a heterogeneous distribution of more 
rapidly sedimenting activity (Fig. 6). One labeled 
polypeptide distributed in the gradient like the 
endogenous activity; it has a molecular weight 
of 62,500. Traces of other labeled polypeptides 
(mainly VPl and VP3, lane D, Fig. 6) were also 
evident but were not selectively distributed in 
the 268 region. 
The broad distribution of enzyme activity in 
Fig. 6 could be a consequence of binding of the 
enzyme to replicative-intermediate RNAs, mol-
ecules that are known to have a broad sedimen-
tation distribution (3). Because of the possibility 
that nuclease could remove the portions of the 
nascent plus strands that were 11.ot hybridized to 
negative strands-and thus could help purify 
the endogenous replicase-the fraction with en-
J . VIROL. 
dogenous replicase was treated with RNase Tl. 
In the presence of 0.2 M KCl, up to 2 p.g of 
RNase T1 per ml (10 min at 37°C) could be 
added without affecting the endogenous activity 
(Table 2) . After treatment with 2 J.l.g of RNAse 
T1 per ml, about 30 to 40% of the input endog-
enous replicase activity was recovered, sedi-
menting at 18 to 208 (Fig. 7). This sedimentation 
rate corresponds to that of poliovirus double-
stranded RNA (2), suggesting that after nuclease 
treatment the replicase stays bound to a double-
stranded RNA core of the replicative interme-
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FIG. 4. Analysis of the viral proteins associated 
with the 78 poly(U) polymerase by polyacrylamide gel 
electrophoresis. (Top) Fraction VI was isolated from 
cells labeled with (d"S]methionine (2.75 to 4.75 h) by 
centrifugation of the cytoplasm at 200,000 x g for 1 h. 
A 0. 7-ml portion of the high-speed supernatant was 
sedimented through a 5 to 20% glycerol gradient at 
38,000 rpm for 22 h at 4° C. The gradient was collected 
in 0.5-ml fractions from the top, and each fraction 
was assayed for polymerase activity. (Bottom) The 
protein composition of each fraction was analyzed 
by NaDodS04-polyacrylamide gel electrophoresis. 
Lanes A and B contained labeled cytoplasmic polio-
virus proteins. Because virions would not be present 
in the 200,000 X g supernatant, VP2 (found only in 
mature virions) should not be present. We therefore 
assume that the band between VPl and VP3 is band 
Y, a protein that previously was found in cells in-
fected with poliovirus-defective interfering particles 
and that migrates in approximately the same position 
as VP2 (11) . BSA, Bovine serum albumin. 
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FIG. 5. Phosphocellulose chromatography (top) 
and polyacrylamide gel electrophoresis (bottom) of 
the 7S poly{U) polymerase. The peak fractions of 
polymerase activity from a glycerol gradient similar 
to the one in Fig. 4 were pooled and applied to a 
phosphocellulose column. The column was washed 
and eluted with a linear salt gradient (0 to 1 M KCl) 
as described in the text. Every second fraction was 
analyzed for poly(U) polymerase activity. The labeled 
proteins in the fractions containing polymerase activ· 
ity were analyzed by polyacrylamide gel electropho· 
resis. No activity was found in the fractions eluted 
from the column at the higher salt concentrations. 
diate and can add nucleotides at gaps in the 
structure. 
When the 18-208 form was prepared from 
[ 358]methionine-labeled cells, a polypeptide of 
molecular weight 62,500 (p63) was the only viral 
polypeptide recovered in the 18 to 208 region 
(Fig. 7). The X-ray film used for the autoradi-
ogram shown in Fig. 7 was sensitive to a level of 
radioactivity about 10 times less than the 
amount of radioactivity present in p63 in frac-
tions 7 and 8 (Fig. 7). If other viral polypeptides 
were present in the 18 to 208 region, then they 
contained less than 10% of the radioactivity pres-
ent in p63. The molecular weight of p63 was 
determined by analyzing a variety of molecular-
weight standards (lanes A and B, Fig. 7) and by 
making a semilogarithmic plot of their molecular 
weights versus the distance of migration in the 
gel. This plot gave a molecular weight of 62,500 
for the replicase protein and 77,000 for NCVP2 
in lane C, Fig. 7. Butterworth (8) previously 
reported a molecular weight of 77,000 for 
NCVP2 in type 2 poliovirus, and Abraham and 
Cooper ( 1) reported a value of 79,000 for NCVP2 
in type 1 poliovirus. Because p63 was the only 
viral protein recovered in the 208 peak, it ap-
pears that p63 is the endogenous replicase pro-
tein. The exact size correspondence of the en-
dogenous replicase protein (Fig. 7) and the 
poly(U) polymerase protein on polyacrylamide 
gels (Fig. 2) suggests that the same protein, p63, 
is responsible for both activities. 
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FIG. 6. Glycerol gradient centrifugation (top) and 
polyacrylamide gel electrophoresis (bottom) of the 
endogenous replicase-template complex. Cell fraction 
IV (Fig. 1) was isolated from infected cells labeled 
with { 35S}methionine, layered on a 15 to 30% linear 
glycerol gradient, and centrifuged in an SW41 rotor 
at 25,000 rpm for 19 h at 4°C. The gradient was 
collected in 0.5-ml fractions from the bottom. The 
direction of centrifugation was from right to left. 
HeLa cell rRNA sedimentation markers were run in 
a parallel gradient. A portion of each fraction was 
assayed for endogenous replicase activity, and the 
labeled proteins in the remainder of each fraction 
were analyzed by NaDodS04·polyacrylamide gel 
electrophoresis as described in the text. Lanes A and 
c contained 35S-labeled poliovirus proteins from an 
infected cytoplasmic extract; lane B contained a por· 
tion of cell fraction IV that was analyzed on this 
gradient; and lane D contained 35S-labeled poliovi· 
rion proteins. 
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TABLE 2. Effect of RNase TI digestion on 
endogenous replicase activity• 
RNaseTl 
{Jtg/ ml) 
0.0 
0.2 
2.0 
20.0 
Replicase activity 
([ 3H]UMP incorporated, 
cpm X 10-3 ) 
8.9 
9.0 
9.9 
3.3 
• Cell fraction IV (5 !Li; Fig. 1) was incubated with 
the indicated amount of RNase T1 in 50 mM HEPES 
(pH 8.0)-33 mM MgCb-0.2 M KCl (10-!Li total vol-
ume) for 10 min at 37°C. Endogenous replicase activity 
was then measured for 10 min at 37°C by adding 115 
!Ll of the standard assay reaction mixture (see text). 
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DISCUSSION 
From these results it appears that the polio-
virus-specified polypeptide p63 is a required 
component of the soluble poly(U) polymerase 
and the template-bound endogenous replicase. 
The poly(U) polymerase appears to be active in 
both a 4S form and 7S form of the enzyme and 
is dependent on a poly(A) template and an 
oligo(U) primer for its activity (15); the endog-
enous replicase mainly copies the negative-
strand template to which it is very tightly bound 
(17). 
Previous studies have indicated that one poly-
peptide predominated in fractions enriched for 
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FIG. 7. Glycerol gradient centrifugation (top) and polyacrylamide gel electroplwresis (bottom) of the RNase 
TI-treated endogenous replicase-template complex. The procedures were as described in the legend to Fig. 6, 
except that cell fraction IV was treated with 2pg of RNase Tl per ml as described in Table 2, footnote a. The 
gradient contained 0.2 M KCl and was centrifuged at 40,000 rpm for 6 h at 4°C. It was collected from the top 
as described in the text, and the direction of centrifugation was from right to left. Fractions I through 13 were 
analyzed on the gel slwwn at the right, and fractions 14 through 22 were analyzed on the gelslwwn at the left. 
Lane A contained labeled vesicular stomatitis virus proteins (G, N, NS, M) synthesized in vitro (19); lane B 
contained unlabeled bovine serum albumin (BSA) and ovalbumin (OA) (detected by staining the gel with 
Coomassie brilliant blue; positions are slwwn in the left margin); lane C contained a portion of fraction IV 
before RNase TI treatment; lane D contained MS-labeled poliovirion proteins; lanes E, F, G, and H contained 
MS-labeled cytoplasmic poliovirus proteins. 
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endogenous replicase activity (9, 23). By diges-
tion with RNase T1, a purification of the endog-
enous replicase to a single viral protein was 
achieved here. The polypeptide we designate as 
p63 appears from its mobility relative to that of 
NCVP2 to be the same polypeptide designated 
in various publications as NCVP3B (14, 25), 
NCVP4 (9, 23), and p58 (1). 
Although p63 is the only viral protein in the 
endogenous replicase, there may be host cell 
proteins involved also. Thus far, we have not 
obtained sufficient protein representing the en-
dogenous replicase to identify or exclude host 
components. Even if p63 acts alone during elon-
gation, there could well be other proteins needed 
for initiation. In fact, it has been suggested that 
the protein found covalently linked to the 5' end 
of poliovirion RNA (designated VPg) acts as a 
protein primer for initiating viral RNA synthesis 
(16, 21). 
The polioviral genome encodes (from 5' to 3') 
three major protein products: NCVP1A, the cap-
sid precursor; NCVPX, a 35,000-dalton poly-
peptide; and NCVP2, a 77,000-dalton poly-
peptide (13). Genetic studies have implied that 
the replicase and capsid precursor are at oppo-
site ends of the genome (13). Furthermore, much 
of NCVP1A can be deleted without reducing 
replicase function (11). These results strongly 
suggest that p63 must be derived from NCVP2 
(and in turn from its short-lived precursor, 
NCVP1.5, or 1B). In confirmation of this sug-
gestion, V. Ambros and D. Baltimore, using the 
technique of Cleveland et al. (10), have shown 
that the partial protease digestion products of 
p63 are present among those of NCVP2 (unpub-
lished data). 
The poly(U) polymerase that was extracted 
from the membrane fraction of infected cells 
with detergent and 2M LiCl appears to be active 
as a 4S monomer of p63. The polymerase from 
the soluble portion of the cytoplasm, however, 
sediments at about 7S and may be a complex of 
p63 and NCVP2 because both proteins cosedi-
ment and co-chromatograph with the activity 
on phosphocellulose. The molecular weight im-
plied by the 7S sedimentation rate is consistent 
with this proposal, but the ratios of radioactivity 
found in NCVP2 and p63 suggest that a 1:1 
complex of p63 plus NCVP2 is not the only 
structure present unless NCVP2 contains much 
more methionine than p63. A dimer of NCVP2 
may also be present, and this would explain why 
about three times as much radioactivity was 
recovered in NCVP2 as in p63. A dimer of p63 
is a third possibility. Further purification and 
characterization will be necessary to clarify these 
relationships. 
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